Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
diarrhea 1 infectiousdiseases
infectious disease 5 infectiousdiseases
plague 1 infectiousdiseases
pneumonia 3 infectiousdiseases
rabies 3 infectiousdiseases
smallpox 1 infectiousdiseases
tularemia 1 infectiousdiseases
diphtheria 2 infectiousdiseases
hepatitis B 2 infectiousdiseases
herpes simplex 1 infectiousdiseases
tetanus 1 infectiousdiseases
toxic shock syndrome 1 infectiousdiseases
viral hepatitis 1 infectiousdiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
diarrhea 41373 all patients with flu have all of the clinical manifestations [[202]]. Some patients may have also diarrhea and vomiting. The flu symptoms tend to last for several days but usually subside within two weeks. However,
diphtheria 6017 and Shibasaburo Kitasato successfully treated diphtheritic children with serum from animals immune to diphtheria [[3], [4]]. Since then, diphtheria antitoxins and many other antitoxins, for example, antitetanus toxin,
diphtheria 6052 treated diphtheritic children with serum from animals immune to diphtheria [[3], [4]]. Since then, diphtheria antitoxins and many other antitoxins, for example, antitetanus toxin, antibotulinum toxin, and antistaphylococcal
hepatitis B 6545 immunization was used also in postexposure prophylaxis for intervention of morbidity [[5]]. For examples, hepatitis B immune globulin (HBIG) is given to subjects exposed to the hepatitis B virus (HBV) through contaminated
hepatitis B 6616 morbidity [[5]]. For examples, hepatitis B immune globulin (HBIG) is given to subjects exposed to the hepatitis B virus (HBV) through contaminated needle stick or sexual exposure or to a newborn of infected mother
herpes simplex 25169 neuropeptide and mastoparan or wasp venom toxin) [[97]], and VP-22 peptide of structural protein of herpes simplex virus [[108]]; (2) amphipathic peptides such as noncytotoxic sweet arrow peptide (SAP) which is a proline-rich
infectious disease 1165 ready-to-use antibodies has gained wide acceptance as a powerful treatment against both infectious and non infectious disease s. Influenza, a highly contagious disease, precipitates annual epidemics and occasional pandemics, resulting
infectious disease 9974 extensively in immunoassays [[14]–[16]], imaging [[17]], and passive immunotherapy of infectious and non infectious disease s [[18], [19]]. The first therapeutic mouse monoclonal antibody, that is, muromonab, which is IgG2a specific
infectious disease 15396 purposes including allergy, autoimmune diseases, cancers, cardiovascular diseases, inflammatory diseases, infectious disease s, and pain [[51], [52]].2.3. In Vitro Production of Human Single-Chain Antibodies by Using Phage Display
infectious disease 22635 antibody cannot do so [[75], [76]]. The sdAbs have become attractive therapeutic molecules for cancers, infectious disease s, parasitic infections, envenomation, intoxication, and inflammatory conditions caused by toxic enzymes
infectious disease 55830 system (no immunogenicity in the recipients) for a safe passive immunization against infections and non infectious disease s can be generated in vitro without a prolonged in vivo immunization process. In our laboratory, human
plague 7949 released infectious biological agents in bioterrorism (biological weapons) such as anthrax, botulinum, plague , smallpox, and tularemia [[9]]. Antibodies may be an adjunct of supportive therapy for infections/intoxications
pneumonia 41704 allergic asthma and chronic lung disease are at risk to severe complications including primary viral pneumonia (uncommon) [[201]] and secondary pneumonia caused by bacteria such as Staphylococcus aureus, Haemophilus
pneumonia 41747 at risk to severe complications including primary viral pneumonia (uncommon) [[201]] and secondary pneumonia caused by bacteria such as Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pneumoniae
pneumonia 41849 pneumonia caused by bacteria such as Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pneumonia e [[203]].3.4. Treatment of Influenza by Using Pharmacologic DrugsThere have been only two families of
rabies 6838 parturition [[5]]. A combination of active and passive immunization has been practiced for intervention of rabies in rabid dog bitten subjects whose bite wounds are serious and/or located near to the central nervous
rabies 6979 bite wounds are serious and/or located near to the central nervous system. In this instance, human rabies immune globulins (HRIG) and rabies vaccines are given concomitantly at different sites; the former is
rabies 7014 located near to the central nervous system. In this instance, human rabies immune globulins (HRIG) and rabies vaccines are given concomitantly at different sites; the former is for providing immediate immunity
smallpox 7957 infectious biological agents in bioterrorism (biological weapons) such as anthrax, botulinum, plague, smallpox , and tularemia [[9]]. Antibodies may be an adjunct of supportive therapy for infections/intoxications
tetanus 6118 diphtheria [[3], [4]]. Since then, diphtheria antitoxins and many other antitoxins, for example, anti tetanus toxin, antibotulinum toxin, and antistaphylococcal toxic shock syndrome toxin-1 (TSST-1), have been
toxic shock syndrome 6177 many other antitoxins, for example, antitetanus toxin, antibotulinum toxin, and antistaphylococcal toxic shock syndrome toxin-1 (TSST-1), have been used for specific treatment of the respective entities. The therapeutics
tularemia 7971 biological agents in bioterrorism (biological weapons) such as anthrax, botulinum, plague, smallpox, and tularemia [[9]]. Antibodies may be an adjunct of supportive therapy for infections/intoxications that direct acting
viral hepatitis 57079 should be of less concern than for treatment of chronic diseases, such as cancers, HIV infection, or viral hepatitis . The potential limitations and challenges during the development of these engineered antibodies towards

You must be authorized to submit a review.